Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Clinical Trials in Nevada

Nevada has 54 clinical trials currently recruiting participants, ranking #36 among all states. The most-studied condition is Parkinson Disease with 2 active trials.

54

Total Trials

54

Recruiting

#36

National Rank

11

Conditions

Trials by Phase

17

Not Applicable

1

Phase 2 / Phase 3

3

Phase 1 / Phase 2

4

Phase 1

11

Phase 2

14

Phase 3

4

Phase 4

Top Conditions in Nevada

Top Sponsors in Nevada

Cities With Most Trials in Nevada

#CityTrials
1Las Vegas37
2Reno15
3Nellis Air Force Base1
4Henderson1
5North Las Vegas1

Important: This information is for research purposes only. Always talk to your doctor about whether a clinical trial is right for you.

Frequently Asked Questions

Nevada currently has 54 clinical trials actively recruiting participants, making it #36 nationally by total trial count.

The most-studied conditions in Nevada are Parkinson Disease (2 trials), Thyroid Eye Disease (2 trials), Ulcerative Colitis (2 trials).

Browse the conditions listed on this page to find trials recruiting in Nevada. Each condition page shows trial details, eligibility criteria in plain English, and contact information. Always talk to your doctor about whether a trial is right for you.

Trial counts reflect currently recruiting studies listed on ClinicalTrials.gov with locations in this state.

The this entity category groups every U.S. clinical trials and research registries entity sharing this attribute. The list above is the data; the paragraphs below explain what the grouping means against the broader the NIH ClinicalTrials.gov registry distribution and how to read the relative rankings within the category.

For readers using this category as a starting point, the per-entity detail pages linked from the table above carry the underlying the NIH ClinicalTrials.gov registry data in full. The category-level view is the filter; the per-entity pages are the actual answer.

Source: ClinicalTrials.gov, 2026.